Zhejiang Guobang Pharmaceutical and Jiangsu Kaiyuan Pharmaceutical signed a strategic cooperation agreement

Dechuang Environmental Protection and Guobang Pharmaceutical Co., Ltd. strategically cooperate to jointly create a demonstration project for hazardous waste packaging and disposal

Zhejiang Guobang Pharmaceutical's 2020 operating income of 4.2 billion yuan, net profit of 810 million yuan

Zhejiang Guobang Pharmaceutical's production capacity of erythromycin and other APIs and intermediate products in 2020

Production and sales statistics of erythromycin and other APIs of Zhejiang Guobang Pharmaceutical from 2018 to 2020

Guangdong Taisende Pharmaceutical Construction of Macrolide Erythromycin API Production Project

Zhejiang Guobang Pharmaceutical's 'Key Technology Innovation and Application of Macrolide Antibiotics Quality Control' project won the third prize of the Provincial Science and Technology Progress Awa

Production volume and sales volume of azithromycin API in Shanghai Hyundai Pharmaceutical in 2020

Ningxia Hengkang Technology Co., Ltd. invests in the technical transformation project with an annual output of 200 tons of erythromycin

Yili Chuanning Biotechnology Co., Ltd. was approved to establish a post-doctoral research station